Despite being a neuropathological hallmark of AD, Aβ correlates weakly with neurodegeneration; rather, it is tau that is associated with brain atrophy and hypometabolism, which, in turn, are related to cognition (Nelson et al., 2012; Bejanin et al., 2017; Jagust, 2018). Here, MAPT is linked to Brain atrophy.